President and CEO
Tissue Regeneration Systems, Inc.
Tissue Regeneration Systems, Inc. (TRS) is seeking to develop and commercialize a full family of skeletal reconstruction implants incorporating novel bioactive scaffold design, manufacturing and coating technologies developed at the Universities of Michigan and Wisconsin over the last decade. The core technology platform at TRS lends itself to the fabrication of implant scaffolds that: i.) resorb over time, fully replacing themselves with natural bone; ii) are load bearing and strong enough to support function without need for reinforcement with metal plates; iii) can be custom constructed using input from patient CT scans; and iv.) are integrated with an osteoconductive coating that enhances bone regeneration and proliferation.
President and CEO
Jim Fitzsimmons is President and CEO of Tissue Regenertion Systems, Inc. (TRS), a start-up medical device company developing novel skeletal reconstruction implants for craniomaxillofacial reconstruction, orthopedic trauma and soft tissure repair, and spine fusion. Prior to TRS, Jim was Chairman and Chief Executive Officer of Archus Orthopedics, Inc., which sold in 2009. Archus was one of three companies created by Scout Medical Technologies LLC, a medical device incubation firm that Jim founded in 2000 and led as Managing Director. In association with his work at Scout, in addition to Archus Orthopedics, Jim co-founded and continues as a Board member of Cardiac Dimensions, Inc, and co-founded EndoGastric Solutions, Inc., both successful start-up medical device companies. Prior to Scout, Jim served as Senior Vice President and General Manager of Guidant Corporation's Cardiac and Vascuar Surgery Group. He joined Guidant in 1997 as a result of its acquisition of EndoVascular Technologies ("EVT"). Jim was President and Chief Executive Officer of EVT for six years prior to the Guidant acquisition. Before that, Jim spent eleven years with the Medical Device and Diagnostic Division of Eli Lilly and Company. During his tenure at Lilly, Jim hled a variety of positions in sales, marketing, mergers and acquisitions, and general management. Outside of his relationship with the Scout companies, Jim serves on the Board of RF Surgical Systems, Inc., a privately held medical device company. He also serves on the Advisory Board of the Albers School of Business and Center for Entrepreneurship at Seattle University. Jim holds a B.S. in Biology-Premedical and a MBA from Seattle University.
Master of Business Administration, Seattle University, 1984; Bachelor of Science in Biology, Pre-Medical, Seattle University, 1978
Mentoring Objectives & Scope
I typically mentor students who work, or want to pursue a career in the life sciences industry. My main objective is to help students identify their career goals and better understand the strategies and pathways required to achieve them. Beyond this I let the students determine discussion topics of interest to them. We usually meet every six weeks. I expect the students to determine the specific topic for each meeting in advance.
When and where do you hold meetings with your students?
Mornings or afternoons in Seattle (Ballard)